Literature DB >> 381941

A structurally abnormal insulin causing human diabetes.

H Tager, B Given, D Baldwin, M Mako, J Markese, A Rubenstein, J Olefsky, M Kobayashi, O Kolterman, R Poucher.   

Abstract

Insulin isolated from the pancreas of a diabetic patient with fasting hyperinsulinaemia showed decreased activity in binding to cell membrane insulin receptors and in stimulating cellular 2-deoxyglucose transport and glucose oxidation. Chemical studies suggest that the isolated hormone is a mixture of normal insulin and an abnormal variant which contains a leucine for phenylalanine substitution at position 24 or 25 of the insulin B-chain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381941     DOI: 10.1038/281122a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

Review 1.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

2.  Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies.

Authors:  G Sesti; M A Marini; A Montemurro; P Borboni; G Di Cola; A Bertoli; R De Pirro; R Lauro
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

3.  Prevalence of beta allele of the insulin gene in type II diabetes mellitus.

Authors:  W Horst-Sikorska; B Zoll; J Kwiatkowska; B Willms; A Kraszewski; A Horst; R Slomski
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

4.  Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.

Authors:  S Shoelson; M Fickova; M Haneda; A Nahum; G Musso; E T Kaiser; A H Rubenstein; H Tager
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.

Authors:  S E Shoelson; K S Polonsky; A Zeidler; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

6.  Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.

Authors:  H Sakura; Y Iwamoto; Y Sakamoto; T Kuzuya; H Hirata
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 7.  Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene.

Authors:  Julie Støy; Donald F Steiner; Soo-Young Park; Honggang Ye; Louis H Philipson; Graeme I Bell
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

8.  Insulin Wakayama: familial mutant insulin syndrome in Japan.

Authors:  K Nanjo; M Miyano; M Kondo; T Sanke; S Nishimura; K Miyamura; K Inouye; B D Given; S J Chan; K S Polonsky
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

9.  Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  M Kishimoto; M Hashiramoto; S Araki; Y Ishida; T Kazumi; E Kanda; M Kasuga
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

10.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.